Serina Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Serina Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2019 to Q2 2024.
  • Serina Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $562K.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $562K Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $627K Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $666K Dec 31, 2023 10-Q 2024-08-09
Q3 2020 $726K $0 0% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $726K +$99K +15.8% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $320K Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $726K Dec 31, 2019 10-K 2021-03-31
Q3 2019 $726K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $627K Jun 30, 2019 10-Q 2020-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.